Now that we are well into the autumn season, all minds turn to influenza. Bird flu warnings are splattered all over the media, with dire warning of hundreds of millions dead (so far, only 60 people have died in a two year period and all have contracted the disease from contaminated chickens), and of course, the beginning of the hype to “get your flu vaccine.”
No shortages are expected this year, and the CDC maintains that vaccination is the best way to protect children younger than 2 and people age 65 years and older from flu and its complications. This remains their official protocol despite substantial evidence to the contrary.
The bottom line is that flu vaccines have not cut death rates or hospitalization rates in either the very young or very old. So why insist that these two groups are the most “at risk” and in need of a vaccine?
Here’s some data to mull over:
The British medical journal The Lancet in September published an analysis of 64 studies evaluating the effectiveness of flu vaccine for the elderly. The analysis found flu shots were only modestly effective, cutting flu-related hospitalizations by 30 percent to 42 percent.
•In February, The Lancet published a similar analysis of 25 studies of flu shots in children younger than 2, the other group targeted by CDC campaigns. There is no evidence vaccination reduces flu-related deaths or complications in that group, researchers concluded.
•A study published in February in the Archives of Internal Medicine examined decades of U.S. data and found no decrease in flu deaths among seniors despite increased vaccine coverage. “There was absolutely no decline in influenza-attributable mortality between 1980, when 15 percent of elderly were vaccinated, and 2000, when 65 percent of elderly were vaccinated,” said Boston flu researcher Dr. Tom Reichert, a co-author of the National Institutes of Health study.
And despite the vaccine shortage last year, there was no increase in the number of flu related deaths or hospitalizations.
Houston Chronicle